Psoriatic Arthritis Trial, Recruiting NCT04014413 Sponsor: Chinese University of Hong Kong Condition: Psoriatic Arthritis
Back to Psoriatic Arthritis

Psoriatic Arthritis Trial, Recruiting

NCT04014413
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been officially diagnosed with Crohn's disease
  • You have been officially diagnosed with ulcerative colitis
  • You have been officially diagnosed with celiac disease
  • You have been officially diagnosed with irritable bowel syndrome (IBS)
  • You have been officially diagnosed with functional dyspepsia (ongoing stomach discomfort or indigestion without a clear cause)
  • You have been officially diagnosed with constipation
  • You have diarrhea or other complications caused by taking antibiotics
  • You have been diagnosed with a metabolic condition such as type 2 diabetes or obesity
  • You have an infection that is resistant to multiple antibiotics
  • You have hepatic encephalopathy (a condition where liver problems affect brain function)
  • You have been diagnosed with multiple sclerosis
  • You have a bowel blockage condition called pseudo-obstruction
  • You have an infection with a bacteria resistant to certain strong antibiotics, such as CRE or VRE (confirm with trial site)
  • You have multiple organ dysfunction (when more than one organ is not working properly)
  • You have a condition involving an imbalance of gut bacteria (dysbiotic bowel syndrome)
  • You have MRSA enteritis or pseudomembranous enteritis (serious gut infections caused by specific bacteria)
  • You have been diagnosed with alopecia (hair loss) or autism
  • You have graft-versus-host disease (a complication that can occur after a transplant)
  • You have idiopathic thrombocytopenic purpura, ITP (a condition affecting blood platelets)
  • You have allergies or atopic conditions such as eczema or asthma
  • You have a liver condition such as fatty liver disease (NAFLD or NASH)
  • You have alcohol dependence
  • You have psoriatic arthropathy (joint disease linked to psoriasis) that has not been well controlled despite standard treatment

Who may not be able to join:

  • You are unable to safely have any of the methods used to deliver the treatment, including tubes through the nose, stomach scopes, bowel scopes, or enemas (confirm with trial site)
  • You have any other condition that the trial doctors believe could affect the treatment's effectiveness or your safety (confirm with trial site)
  • You are currently pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Siew Ng, Chinese University of Hong Kong

Phone: +852 35053855

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
15 July 2019
Est. completion
31 October 2030

Where this trial is recruiting

Hong Kong

Primary endpoints

The efficacy of FMT in treating dysbiosis-associated disorder will be assessed by number of patients who have improvement in clinical symptoms (depends on each disease as stated in outcome)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov